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Abstract 
Objective: Analyze whether the most frequent cases of non-dysplastic leukoplakias, hyperkeratosis (H), acantho-
sis (A), and hyperkeratosis with acanthosis (HA) have similar cell proliferation rates and to compare them with 
epithelial dysplastic (ED) leukoplakias and normal oral epithelium (NOE).Study design: The sample comprised 
10 cases of normal oral epithelium, 10 cases of hyperkeratosis, 10 cases of acanthosis, 10 cases of hyperkeratosis 
with acanthosis and 10 cases of epithelial dysplasia. The mean number of AgNORs per nucleus (mAgNOR) and 
the mean percentage of cells with 1, 2, 3 and 4 or more AgNORs per nucleus (pAgNOR) were recorded. Results: 
The results of mAgNOR showed differences between disorders in the evaluation of the basal layer, of the para-
basal layer, and in the overall evaluation. mAgNOR and pAgNOR=2 increased progressively from normal oral 
epithelium to hyperkeratosis with acanthosis, hyperkeratosis, acanthosis and epithelial dysplasia (p<0.05). Cell 
proliferation rate was different between different subtypes of non-dysplastic leukoplakias and this group present-
ed a higher proliferative behavior when compared to normal oral epithelium. Conclusion: It may be suggested that 
non-dysplastic leukoplakias had different characteristics regarding cell proliferation rates and sometimes showed 
a proliferative behavior similar to that found in epithelial dysplasia. More studies should be conduced to increase 
knowledge about the biological profile of non-dysplastic leukoplakias, especially as it pertains to acanthosis.
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Introduction 
Leukoplakia, a common lesion of the oral mucosa, is 
defined as any white patch or plaque not clinically or 
histologically characterized as any other disease (1). It 
is a diagnosis made by exclusion of any other known 
disease or disorder. Microscopically, this lesion may 
be characterized by a range of disorders in epithelial 
renewal and maturation, such as hyperkeratosis, acan-
thosis or epithelial dysplasia (1-3). Waldron and Shafer 
(2) after a microscopic analysis of 3,256 leukoplakias, 
detected that 80.1% showed different matches of hyper-
orthokeratosis, hyperparakeratosis and acanthosis.
According to van der Waal (3), the term leukoplakia can 
be used at different levels of certainty, as a clinical term 
only or as a clinicopathological term. The clinical term 
is based on evidence obtained by a negative result of 
elimination of suspected etiologic factors, during a fol-
low-up period of 2-4 weeks or in the absence of any sus-
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pected etiologic factors. The clinicopathological term is 
based on a clinical definitive diagnosis complemented 
by incisional biopsy or excision and pathological exami-
nation of the resected specimen (definitive histopatho-
logical diagnosis).
Nucleolar organizer regions (NORs) are DNA segments 
that encode ribosomal RNA (4,5). During transcription, 
these regions bind to argyrophilic nucleolar organizer 
regions (AgNOR) proteins. A high number of AgNOR 
dots are observed in proliferating cells (4,6,7). The 
number of AgNOR dots provides information about the 
velocity of cell proliferation during the cell cycle (cell 
proliferation rate), differently from most proliferation 
markers, which only indicate whether cells are or are 
not undergoing division (cell growth fraction) (6). Some 
studies found a progressive increase in the mean num-
ber of AgNOR counts as the oral epithelium undergoes 
maturation and reaches malignant transformation (8,9). 
According to Pich et al. (10), it is the rate of cell prolif-
eration, rather than the proliferative activity per se, that 
affects neoplastic progression.
Most studies classify all non-dysplastic leukoplakias 
into one single group, although different epithelial dis-
orders may be observed. Carcinomatous transformation 
may also take place in non-dysplastic leukoplakia (11) 
and genetic changes, particularly, at chromosome 3, 
have been demonstrated in the majority of keratotic and 
non-dysplastic lesions (12).
This study evaluated the cell proliferation rates in the 
most frequent cases of non-dysplastic leukoplakias, 
hyperkeratosis (H), acanthosis (A), and hyperkeratosis 
with acanthosis (HA). The aim of this study was to ana-
lyze whether these three non-dysplastic leukoplakias 
had similar cell proliferation rates and to compare them 
with epithelial dysplastic (ED) leukoplakias and normal 
oral epithelium (NOE). 
Material and Methods 
The sample comprised 10 gingival specimens of NOE 
and 40 cases of oral leukoplakia, whose patients were 
submitted to biopsies at the Dentistry School of the 
Universidade Federal do Rio Grande do Sul. The aver-
age age of patients diagnosed with oral leukoplakia was 
50.3 years old. The sample was composed of 19 males 
and 21 females. All patients included in this study pre-
sented clinically solitary, homogenous and non-ulcer-
ative leukoplakia, and absence of Candida albicans. The 
patients were followed-up for a period of 3 to 5 years 
and presented no recurrence, new leukoplakia lesion 
or progression to oral squamous cell carcinoma. All le-
sions were submitted to excisional biopsies, as they did 
not exceed 2cm. The most common anatomic site of the 
leukoplakias was in gingiva (n=15) followed by  tongue 
(n=9), buccal mucosa (n=7), lip (=6), palate (n=2) and 
floor of the mouth (n=1). The race of the subjects was 
scored as "white" (n=37) or "non-white" (n=3), since the 
study group included only a small percentage of other 
ethnic groups. 
Based on a previous study our group (unpublished), in the 
macroscopic analysis, the fragment was sectioned longi-
tudinally at the central portion, and in the preparation of 
paraffin blocks, the two fragments were positioned so 
that the histological sections could show the whole exten-
sion of the epithelium in the center of the lesion.
All 40 specimens with clinical leukoplakia diagnoses 
presented the following microscopic diagnoses: acan-
thosis (n=10), hyperkeratosis (hyperparakeratosis and 
hyperorthokeratosis) (n=10), hyperkeratosis with acan-
thosis (n=10) and epithelial dysplasia (n=10).
Hyperkeratosis was defined as an increase in the thick-
ness of the keratin layer; and acanthosis, as an increase 
in the number of cells in the prickle layer with preserved 
epithelial stratification and no cellular atypia. When 
these two disorders were found together, specimens 
were classified as having hyperkeratosis with acantho-
sis. These diagnoses always contemplated the peculiari-
ties of the anatomic site where the lesion occurs. Epithe-
lial dysplasia was defined as at least two architectural 
and two cytological abnormalities, classified according 
to the World Health Organization criteria (3).
Architectural abnormalities were: irregular epithelial 
stratification, loss of polarity of basal cells, drop-shaped 
rete ridges, increased number of mitotic figures, abnor-
mally superficial mitoses, dyskeratosis, and keratin 
pearls within rete ridges. Cytological disorders were: 
abnormal variation in nuclear size and shape and in cell 
size, cellular pleomorphism, increased nuclear-cyto-
plasmic ratio, atypical mitotic figures, increased num-
ber and size of nucleoli, and hyperchromasia (3).
There is a substantial interobserver and intraobserver 
variation in the histopathological assessment of the 
presence and severity of epithelial dysplasia (3). It was 
suggested that a binary system to assess dysplasia (no/
questionable/mild-low risk; moderate/severe-high risk) 
may increase the likelihood of agreement between pa-
thologists (13). Our option in this study was to classify 
epithelial dysplasia as absent or present, mainly because 
our focus was to analyze non-dysplastic leukoplakias 
and use dysplasia just as a positive control of a poten-
tially malignant disorder.
Two 3-μm sections were obtained from each paraffin 
block; one was stained with haematoxylin-eosin (HE) 
for morphological analysis and adjustment between the 
two examiners (M.S.F. and L.C.H.); and the other one 
was stained for visualization of AgNORs and evalu-
ation of epithelial proliferation rate according to the 
method described by Ploton et al. (14). Silver staining 
was performed at 25° C for 25 minutes. Typical micro-
scopic fields from each disorder were selected on the 
HE-stained slides (Fig.1. A, B, C and D). Correspond-
e330
Med Oral Patol Oral Cir Bucal. 2010 Mar 1;15 (2):e328-34.                                                                                                                                 Cell proliferation in non-dysplastic leukoplakias
ing images of the silver-stained slides were captured us-
ing a video camera (JVC™, 1 CCD, TK-C 620, color: 
JVC, Yokohama, Japan) coupled to a binocular micro-
scope (CH 30, Olympus Optical Co. Ltd., Tokyo, Japan) 
at 400x magnification. The images were recorded at a 
440 x 330 pixel resolution using Microsoft VidCap for 
Windows 95 (Microsoft Corp., Redmond, WA, USA) 
installed on an Aquanta DX computer (Unisys, Blue 
Bell, Pennsylvania, USA).
Images were transferred to the Imagelab™ 2.3 software 
(Sistema de Processamento e Análise de Imagens, Sof-
tium-Sistemas de Informática, São Paulo, Brazil). Ag-
NOR counts were obtained using the software’s manual 
count tool.
The basal layer had cells with at least one contact sur-
face with the basement membrane. The parabasal layer 
was more superficial than the basal layer and was found 
within two layers above the basement membrane and 
next to the basal layer (15). However, the shape of para-
basal layer cells was not flattened, which is typical of 
superficial layer cells. Microscopic fields with subepi-
thelial inflammatory infiltrate, overlapping cells, and 
areas of artifact were excluded. On each slide, 100 to 
150 nuclei per layer were assessed.
AgNOR counts were recorded as mean AgNOR number 
per nucleus (mAgNOR) and percentage of cells with 1, 2, 
3 and 4 or more AgNOR counts per nucleus (pAgNOR). 
Dots that could not be distinguished from each other 
were counted as a single dot, following the standardized 
counting method described by Crocker et al. (16).
Examiners were trained by an advising professor to 
standardize counting criteria. Intraobserver adjustment 
for AgNOR counting was conducted by recounting one 
out of every six images. The readings obtained in the 
first and second counts were compared using Student’s 
t test for paired samples (p>0.6). An examiner who was 
unaware of which group the slides belonged to per-
formed the analysis.
Analysis of variance (ANOVA) was used to compare the 
means between groups since the data followed normal 
distribution, as verified by Kolmogorov Smirnov test. 
Statistical significance was considered when p<0.05. 
Tukey test was performed for multiple comparison. The 
data were processed and analyzed using the Statistical 
Package for the Social Sciences (SPSS) version 10.0.
This study was approved by the Research and Ethics 
Committee of the School of Dentistry, Universidade 
Federal do Rio Grande do Sul (no. 90/02). 
Results 
AgNORs were seen as black dots in the yellow nucleus of 
epithelial cells in all groups (Fig.1. E, F, G and H). The re-
sults of mAgNOR showed differences between disorders 
in the evaluation of the basal layer, of the parabasal layer, 
and in the overall evaluation. Overall results showed that 
proliferation rate was higher in A and ED than in NOE. 
The values of mAgNOR increased progressively from 
NOE to HA, H, A and ED. The NOE group showed 
significantly lower mAgNOR values in the basal layer 
than the ED group. In A, ED and H, mAgNOR in the 
parabasal layer was significantly higher than in NOE. In 
groups A and ED, pAgNOR=1 was lower and mAgNOR 
was statistically greater than in NOE (Tables 1 and 2).
When pAgNOR was compared between groups, cells 
with 1 AgNOR count per nucleus were predominant 
(Table 2). The NOE group had the highest percentage of 
cells with 1 AgNOR count. Statistically significant dif-
ferences in pAgNOR=2 were detected between A, ED 
and NOE. The behavior of this parameter was similar 
to that of mAgNOR, with the number of AgNOR counts 
per nucleus increasing progressively from NOE to HA, 
H, A and ED. None of the two AgNOR counting me-
thods was capable to distinguish between the diffe-rent 
types of epithelial disorders. 
Basal Layer Parabasal Layer Overall
n Mean (SD) p Mean (SD) p Mean (SD) p
Normal oral epithelium 10 1.49 (0.26)B 0.014* 1.39 (0.16)B 0.01* 1.43 (0.17)A 0.01*
Hyperkeratosis 10 1.78 (0.29)AB 1.96 (0.51)A 1.87 (0.39)AB
Hyperkeratosis with acan-
thosis 10 1.74 (0.48)
AB 1.83 (0.42)AB 1.84 (0.52)AB
Acanthosis 10 1.89 (0.30)AB 1.98 (0.43)A 1.94 (0.35)B
Epithelial Dysplasia 10 2.12 (0.71)A 2.01 (0.28)A 2.02 (0.32)B
Table 1. Proliferative activity evaluation by means of mAgNOR distribution in normal oral epithelium and in oral epithelial disturbances.
Means (with standard deviation in parentheses) followed by the same letter are not significantly different from each other (ANOVA 
p>0.05).
e331
Med Oral Patol Oral Cir Bucal. 2010 Mar 1;15 (2):e328-34.                                                                                                                                  Cell proliferation in non-dysplastic leukoplakias
Fig. 1. Photomicrograph of HA (a: HE-stained; e: AgNOR-stained) H (b: HE-stained; f: AgNOR-stained), A (c: HE-stained; g: 
AgNOR-stained) and ED (c: HE-stained; h: AgNOR-stained). Original magnification 200x (HE) and 400x (AgNOR).  
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Discussion 
Oral leukoplakia has been extensively studied in the 
literature, and most studies have compared dysplastic 
with non-dysplastic leukoplakias classified into a sin-
gle group. This study assessed the differences in cell 
proliferation rates between three non-dysplastic lesions 
and compared them with normal oral epithelium and 
epithelial dysplasia. Studies of epithelial disorders in 
leukoplakias showed that epithelial dysplasia was fre-
quently associated with an increased risk of malignant 
transformation. However, several studies showed that 
malignant transformation might occur even when epi-
thelial dysplasia was absent (11,13,17).
The border of the tongue and the floor of the mouth have 
been considered as high-risk sites in cancer develop-
ment (11). At the same time, leukoplakia can affect any 
site of the oral cavity (3). Johann  et al. (18) in a study of 
metallothionein immunoexpression in oral leukoplakia, 
showed no significant difference between regions of 
high and low risk of malignant change. In this study, the 
inclusion criteria were targeted at standardizing some 
aspects of the sample, such as clinical aspect and lesion 
size. In addition, we were careful to consider the mor-
phological characteristics of the anatomic site of lesions 
in the histopathological analysis.
In a previous study (unpublished), in which lesions with 
histopathological diagnosis of  hyperkeratosis with acan-
thosis, hyperkeratosis and dysplasias were examined in 
three or more step sections distributed throughout the 
specimen; and in which the number of step sections de-
pended on the size of the specimens, 23.5% of the cases 
of hyperkeratosis and hyperkeratosis with acanthosis 
showed areas of dysplasia. Based on these results, we 
adopted the excisional biopsy protocol for leukoplaki-
as with a single lesion measuring around 2cm. In the 
macroscopic analysis, these specimens were sectioned 
longitudinally at the central portion and embedded in 
paraffin blocks in such a way that the histological slide 
could show the whole extension of the epithelium of 
p AgNOR=1 p AgNOR=2 p AgNOR=3 p AgNOR≥4
Overall Layers n Means (SD) p Means (SD) p Means± SD p Means (SD) p
Normal oral 
epithelium 10 65.07 (12.19)
A 0.01* 27.27 (7.85)A 0.01* 6.45 (4.46)A 0.02* 1.21(1.16) 0.12
Hyperkeratosis 10 45.13±13.84B 32.88(2.54)AB 15.62 (8.88)AB 6.37(7.22)
Hyperkeratosis 
with acanthosis 10 46.41 (20.16)
B 32.04 (5,96)
AB 15.06 (10.05)AB 6.60 (10.31)
Acanthosis 10 39.33 (11.53) B 37.33 (4.87)B 16.31(7.77)AB 7.02(6.58)
Epithelial 
Dysplasia 10 37.25 (9.66)
B 34.77 (5.30)B 18.15 (7.26)B 9.84(7.01)
Table 2. Proliferative activity evaluation by means of pAgNOR distribution in normal oral epithelium and in oral epithelial disturbances.
Means (with standard deviation in parentheses) followed by the same letter are not significantly different from each other (ANOVA p>0.05).
both halves. We thus believe that the histopathological 
diagnosis reflects the true nature of the lesion. Holm-
strup et al. (19), in a retrospective study to learn whether 
an incisional biopsy of oral premalignant lesions, leu-
koplakia and erythroplakia, showed histopathological 
findings representative of the whole surgically removed 
lesion, observed underdiagnosis in 35% of the incisional 
biopsies, and stepwise sectioning revealed seven unex-
pected carcinomas (7%).
Although the biological significance of AgNOR counts 
has not been fully explained so far, the association bet-
ween AgNOR counts and cell cycle kinetics has been 
demonstrated in many studies. The link between cell 
proliferation, cancer and nucleolar activity has been 
well established during the past several decades (5). It 
was shown that AgNOR counts may be associated with 
other proliferation markers, such as PCNA and Ki-67 
(20), and that their counts may be reliable proliferation 
markers. We believe that AgNOR counts should not be 
directly compared with other usual proliferation mark-
ers. AgNOR counts provide information about the rate 
at which cells are dividing, whereas usual immunohis-
tochemical markers indicate only whether cells are or 
are not undergoing division. Kaplan, Engelberg, and 
Dayan (21) found strong evidence of AgNOR sensi-
tivity in the early detection of intranuclear changes. 
Chattopadhyay and Ray (22) suggested the use of a 2.3 
cutoff point to distinguish between mild and moderate 
dysplastic leukoplakias. Although such measurements 
are important, comparisons between studies are diffi-
cult because of the use of different AgNOR protocols 
and counting methods.
Xie et al. (4) used mAgNOR counts and found that 
proliferation rates increased from normal epithelium 
to leukoplakia and to carcinoma, but were not able to 
distinguish dysplastic from non-dysplastic leukoplaki-
as.  Our findings are in agreement with their results: we 
were also unable to detect significantly different proli-
feration rates between H, HA, A and ED, and this may 
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be due to the limited number of samples collected for 
this study. However, Warnakulasuriya and Johnson (9) 
found lower mAgNOR values in hyperkeratosis than in 
dysplasia and squamous cell carcinoma.
According to Xie et al. (4), the evaluation of pAgNOR is 
easier and less cumbersome to perform than the conven-
tional mAgNOR technique, and it does not need sophis-
ticated equipment as is required for area measurement. 
In our opinion, pAgNOR provides a more complete 
evaluation of epithelial renewal than mAgNOR and 
measures the number of cells that are proliferating faster 
in the tissue under study. Our study showed that ED had 
a higher number of pAgNOR=3 and pAgNOR≥4 than 
NOE (Table 2), which indicates that ED had more cells 
proliferating fast than NOE. A and ED had significantly 
higher numbers of pAgNOR=2 than NOE, a finding 
similar to that observed for mAgNOR. This was expec-
ted because A had an increased proliferative activity in 
the prickle cell layer, and at least part of it was analyzed 
in the parabasal layer. The most reliable parameter was 
pAgNOR because it detected the highest cell prolifera-
tion rate in A. Our results showed that the proliferative 
behavior of A is similar to that of ED. Further studies 
should investigate other features of acanthosis, such as 
cell adhesion and collagen degradation, to improve our 
knowledge about this disorder.
Previous studies demonstrated the role of the parabasal 
layer in the increase of cell proliferation to maintain 
tissue homeostasis against exogenous stimuli (15). We 
believe that progressive enlargement of proliferative 
compartments may be a sign of the progression of the 
malignant process. Shin et al. (23) found a gradual in-
crease in PCNA labeling index in basal, parabasal and 
superficial layers, and that this index reached its high-
est value in dysplastic epithelium. We agree with Liu 
et al. (8), who suggested that the analysis of superficial 
and basal layers is the most useful tool to distinguish 
between normal and abnormal epithelium. Differences 
may be more difficult to detect in the basal layer be-
cause it is constantly undergoing physiological division. 
Therefore, our results suggest that the most useful layer 
for the detection of cell proliferation disorders is the 
parabasal layer, which is in agreement with the findings 
by Liu et al. (8) and Oliver et al. (15). In the oral epi-
thelium, asymmetrical cell division in epithelial stem 
cells located in the basal layer may produce transient 
amplifying cells located in the parabasal layer. In ad-
dition, loss of asymmetrical cell division may lead to 
increasing numbers of stem cells in the parabasal layer, 
as shown by the increase in p63 positive cells (24). It is 
well established that the loss of basal cell polarity is a 
histological criterion and a hallmark of cellular atypia 
in epithelial dysplasia.
In summary, our results showed that these three non-
dysplastic leukoplakias had some differences in cell 
proliferation rates among them and that some results 
were similar to those found in ED. These results sug-
gest that more detailed studies of non-dysplastic leuko-
plakias biological profiles are needed due to the diffe-
rent results of each cell proliferation rate, in particular 
acanthosis. 
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